Literature DB >> 3708579

Stimulation of tumor growth in adult rats in vivo during an acute fast.

L A Sauer, W O Nagel, R T Dauchy, L A Miceli, J E Austin.   

Abstract

These experiments investigate an increase in tumor growth that occurs in adult rats in vivo during an acute fast. The effects of feeding, fasting, and underfeeding on the growth of Morris hepatomas 5123C and 7288CTC in Buffalo rats and of Walker carcinoma 256 and Jensen sarcoma in Sprague-Dawley rats were studied. Animals were matched for tumor size and growth during a period of ad libitum feeding preceding the fasting or underfeeding. Tumor growth was documented by increased size and incorporation of [methyl-3H]thymidine into tumor DNA. Fasting increased the rate of growth of the tumors 3 to 4 times over that measured in fed rats. This effect began during the first day of fasting and ended abruptly on refeeding. After refeeding tumor growth slowed to the rate in fed rats. Tumors from fed or fasted rats were not different in cellularity or dry weight/g wet weight. A positive growth response in the tumor required lipolysis and ketosis in the host. No stimulation was observed during an acute fast in either immature rats or in mature rats whose weights had been reduced by underfeeding. These animals have small fat stores and show no increase in arterial blood free fatty acid or ketone body concentrations during an acute fast. Finally, underfeeding of adult rats raised the blood concentrations of these nutrients to values that were intermediate between those in fasted and fed rats. Tumor growth rates in these rats were intermediate between those in fasted and fed rats. The results support the proposal that an increase in availability of free fatty acids and/or ketone bodies is the stimulus that increases the rate of tumor growth during an acute fast.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708579

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Adaptive alterations in cellular metabolism with malignant transformation.

Authors:  C P Fischer; B P Bode; W W Souba
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

Review 2.  Important aspects of nutrition in children with cancer.

Authors:  Jacqueline Bauer; Heribert Jürgens; Michael C Frühwald
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

3.  A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats.

Authors:  Robert T Dauchy; Erin M Dauchy; Lulu Mao; Victoria P Belancio; Steven M Hill; David E Blask
Journal:  Comp Med       Date:  2012-04       Impact factor: 0.982

4.  A Method for Growing Tissue-Isolated Human Tumor Xenografts in Nude Rats for Melatonin/Cancer Studies.

Authors:  Robert T Dauchy; Steven M Hill; David E Blask
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Glutamine and cancer.

Authors:  W W Souba
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

6.  Acetoacetate metabolism in AS-30D hepatoma cells.

Authors:  D A Briscoe; G Fiskum; A L Holleran; J K Kelleher
Journal:  Mol Cell Biochem       Date:  1994-07-27       Impact factor: 3.396

Review 7.  Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence.

Authors:  Michelle N Harvie; Tony Howell
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

Review 8.  Improved biochemical strategies for targeted delivery of taxoids.

Authors:  Thota Ganesh
Journal:  Bioorg Med Chem       Date:  2007-03-18       Impact factor: 3.641

Review 9.  The role of inflammatory pathways in cancer-associated cachexia and radiation resistance.

Authors:  Aaron Laine; Puneeth Iyengar; Tej K Pandita
Journal:  Mol Cancer Res       Date:  2013-06-20       Impact factor: 5.852

Review 10.  The role of triglyceride lipases in cancer associated cachexia.

Authors:  Suman K Das; Gerald Hoefler
Journal:  Trends Mol Med       Date:  2013-03-14       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.